Return
Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms
J
A
R
M
T
A
K
Y
G
B
J
R
L
S
G
J
DOI:10.1016/j.ccell.2026.06.008.png)
Abstract
En 中文
• Menin inhibition suppresses megakaryopoiesis via downregulation of MEF2C and MEIS1 • Menin inhibition selectively affects megakaryocyte progenitors • Menin inhibitor revumenib has anti-tumor activity in pre-clinical models of the MPNs
Keywords:
menin
myeloproliferative neoplasms
revumenib
megakaryocyte
Journal
IF:
44.5
Papers:
413
Citations:
5.6W
